美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

克利夫蘭生物實驗室

3.17

0.0000

成交量：- -

成交額：- -

市值：1.08億

市盈率：-4.27

高：3.17

開：3.17

低：3.17

收：3.17

52周最高：10.97

52周最低：1.62

股本：3,396.14萬

流通股本：3,363.31萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.7424

每股收益(LYR):-0.5610

淨資產收益率：-31.86%

總資產收益率：-20.33%

市淨率：-23.01

市盈率(LYR):-5.65

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

克利夫蘭生物實驗室

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.cytocom.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Cytocom Inc.於2003年6月5日根據特拉華州的法律註冊成立，總部設在紐約州布法羅市。Cytocom, Inc.是一家臨床階段的生物製藥公司，基於旨在重新平衡人體免疫系統和恢復體內平衡的專有平台，開發針對自身免疫、炎症、傳染病和癌症的新型免疫療法。Cytocom正在開發旨在直接在患者體內引發抗原特異性殺傷性T細胞和抗體的強大而持久的反應的療法，從而激活針對自身免疫、炎症、傳染病和癌症的基本免疫防禦。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CBLI/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CBLI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBLI\",,,,,undefined,":{"symbol":"CBLI","market":"US","secType":"STK","nameCN":"克利夫蘭生物實驗室","latestPrice":3.17,"timestamp":1630440000000,"preClose":3.17,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":33633122,"shares":33961397,"eps":-0.742434,"marketStatus":"盤前交易","change":0,"latestTime":"03-23 04:25:01 EDT","open":3.17,"high":3.17,"low":3.17,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.742434,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774272600000},"marketStatusCode":1,"symbolChange":{"newSymbol":"STAB","executeDate":"2021-09-01"},"adr":0,"adrRate":0,"listingDate":1153454400000,"exchange":"NASDAQ","adjPreClose":3.17,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBLI\",,,,,undefined,":{"symbol":"CBLI","floatShares":33633122,"roa":"-20.33%","roe":"-31.86%","lyrEps":-0.560974,"shares":33961397,"dividePrice":0,"high":3.17,"amplitude":0,"preClose":3.17,"low":3.17,"week52Low":1.62,"pbRate":"-23.01","week52High":10.9718,"institutionHeld":0.0254,"latestPrice":3.17,"eps":-0.742434,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.742434,"open":3.17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CBLI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-09-01","symbol":"CBLI","oldSymbol":"CBLI","defaultRemindTime":1630503000000,"newSymbol":"STAB","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1630468800000},{"market":"US","date":"2021-08-16","symbol":"CBLI","fiscalQuarterEnding":"2021/06","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1629086400000,"reportTimeType":"pre","actualEps":-0.04},{"market":"US","date":"2020-12-31","symbol":"CBLI","fiscalQuarterEnding":"2020/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1609390800000,"reportTimeType":"","actualEps":-0.04},{"market":"US","date":"2020-05-15","symbol":"CBLI","fiscalQuarterEnding":"2020/03","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1589515200000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2019-11-14","symbol":"CBLI","fiscalQuarterEnding":"2019/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1573707600000,"reportTimeType":"","actualEps":-0.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CBLI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CBLI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CBLI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CBLI","date":"2021-08-31","current":-4.26974,"percent":0.458738,"low":-52.824616,"twenty":-15.425424,"median":-5.157155,"eighty":-1.832923,"high":388.25966,"avg":7.416056,"sd":74.849212,"marketCap":116147977},"quantilePoints":[{"date":"2021-03-26","current":-35.859444,"twenty":-15.017016,"median":-4.68111,"eighty":-1.792138,"marketCap":86007334},{"date":"2021-04-01","current":-33.860086,"twenty":-15.143646,"median":-4.746392,"eighty":-1.792616,"marketCap":81211961},{"date":"2021-04-09","current":-38.181278,"twenty":-15.381162,"median":-4.830199,"eighty":-1.802371,"marketCap":91576154},{"date":"2021-04-16","current":-38.568251,"twenty":-15.610372,"median":-4.906041,"eighty":-1.816521,"marketCap":92504291},{"date":"2021-04-23","current":-31.538252,"twenty":-15.813114,"median":-5.034944,"eighty":-1.818787,"marketCap":75643141},{"date":"2021-04-30","current":-35.472471,"twenty":-15.974877,"median":-5.085748,"eighty":-1.828161,"marketCap":85079197},{"date":"2021-05-07","current":-34.053572,"twenty":-16.016893,"median":-5.163362,"eighty":-1.828712,"marketCap":81676029},{"date":"2021-05-14","current":-29.151922,"twenty":-16.212362,"median":-5.249933,"eighty":-1.839826,"marketCap":69919631},{"date":"2021-05-21","current":-33.730929,"twenty":-16.212362,"median":-5.249933,"eighty":-1.839826,"marketCap":79200998},{"date":"2021-05-28","current":-34.060333,"twenty":-16.212362,"median":-5.249933,"eighty":-1.839826,"marketCap":79974445},{"date":"2021-06-04","current":-34.982663,"twenty":-16.212362,"median":-5.249933,"eighty":-1.839826,"marketCap":82140097},{"date":"2021-06-11","current":-36.102635,"twenty":-16.212362,"median":-5.249933,"eighty":-1.839826,"marketCap":84769818},{"date":"2021-06-18","current":-31.95215,"twenty":-16.212362,"median":-5.249933,"eighty":-1.839826,"marketCap":75024383},{"date":"2021-06-25","current":-33.533287,"twenty":-16.180697,"median":-5.247502,"eighty":-1.839467,"marketCap":78736930},{"date":"2021-07-02","current":-37.156727,"twenty":-16.180697,"median":-5.247502,"eighty":-1.839467,"marketCap":87244849},{"date":"2021-07-09","current":-31.886269,"twenty":-16.180697,"median":-5.247502,"eighty":-1.839467,"marketCap":74869693},{"date":"2021-07-16","current":-27.274619,"twenty":-16.149032,"median":-5.234514,"eighty":-1.839108,"marketCap":64041432},{"date":"2021-07-23","current":-31.293343,"twenty":-16.149032,"median":-5.234514,"eighty":-1.839108,"marketCap":73477488},{"date":"2021-07-28","current":-32.87448,"twenty":-16.149032,"median":-5.234514,"eighty":-1.839108,"marketCap":77190035},{"date":"2021-08-13","current":-6.637051,"twenty":-15.848059,"median":-5.169569,"eighty":-1.83539,"marketCap":111053768},{"date":"2021-08-20","current":-6.292005,"twenty":-15.731226,"median":-5.169569,"eighty":-1.83539,"marketCap":105280330},{"date":"2021-08-27","current":-7.063283,"twenty":-15.550463,"median":-5.157155,"eighty":-1.832923,"marketCap":118185661},{"date":"2021-08-31","current":-6.941503,"twenty":-15.425424,"median":-5.157155,"eighty":-1.832923,"marketCap":116147977}],"updateTime":1774246604625},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.cytocom.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Cytocom Inc.於2003年6月5日根據特拉華州的法律註冊成立，總部設在紐約州布法羅市。Cytocom, Inc.是一家臨床階段的生物製藥公司，基於旨在重新平衡人體免疫系統和恢復體內平衡的專有平台，開發針對自身免疫、炎症、傳染病和癌症的新型免疫療法。Cytocom正在開發旨在直接在患者體內引發抗原特異性殺傷性T細胞和抗體的強大而持久的反應的療法，從而激活針對自身免疫、炎症、傳染病和癌症的基本免疫防禦。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.440046},{"month":2,"riseRate":0.466667,"avgChangeRate":0.034696},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.038641},{"month":4,"riseRate":0.533333,"avgChangeRate":0.08618},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.042743},{"month":6,"riseRate":0.6,"avgChangeRate":0.046106},{"month":7,"riseRate":0.357143,"avgChangeRate":-0.046329},{"month":8,"riseRate":0.4375,"avgChangeRate":-0.064742},{"month":9,"riseRate":0.666667,"avgChangeRate":0.060809},{"month":10,"riseRate":0.4,"avgChangeRate":-0.032767},{"month":11,"riseRate":0.4,"avgChangeRate":-0.040879},{"month":12,"riseRate":0.266667,"avgChangeRate":-0.050803}],"exchange":"NASDAQ","name":"克利夫蘭生物實驗室","nameEN":"Cleveland BioLabs"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CBLI\",market:\"US\",,,undefined,":null}}